Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911039 | Lung Cancer | 2013 | 5 Pages |
Abstract
The identification of T790M as acquired resistance mechanism was clinically feasible. Although T790M had no prognostic or predictive role in the present study, further research is necessary to identify patients with T790M-mutant tumors who might benefit from newly developed T790M-specific TKIs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jong-Mu Sun, Myung-Ju Ahn, Yoon-La Choi, Jin Seok Ahn, Keunchil Park,